> top > projects > Inflammaging > docs > PubMed:27110920 > annotations
Inflammaging  

PubMed:27110920 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T1 0-165 Sentence denotes The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
T1 0-165 Sentence denotes The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
T2 166-177 Sentence denotes BACKGROUND:
T2 166-177 Sentence denotes BACKGROUND:
T3 178-359 Sentence denotes A large proportion (25-46%) of adults with inflammatory bowel disease in remission has symptoms of irritable bowel syndrome (IBS), which are thought to reflect ongoing inflammation.
T3 178-359 Sentence denotes A large proportion (25-46%) of adults with inflammatory bowel disease in remission has symptoms of irritable bowel syndrome (IBS), which are thought to reflect ongoing inflammation.
T4 360-427 Sentence denotes Data on paediatric inflammatory bowel disease patients are lacking.
T4 360-427 Sentence denotes Data on paediatric inflammatory bowel disease patients are lacking.
T5 428-432 Sentence denotes AIM:
T5 428-432 Sentence denotes AIM:
T6 433-643 Sentence denotes To investigate (i) the prevalence of IBS-type symptoms in paediatric inflammatory bowel disease patients in remission and (ii) the relationship of IBS-type symptoms with biochemical markers of disease activity.
T6 433-643 Sentence denotes To investigate (i) the prevalence of IBS-type symptoms in paediatric inflammatory bowel disease patients in remission and (ii) the relationship of IBS-type symptoms with biochemical markers of disease activity.
T7 644-652 Sentence denotes METHODS:
T7 644-652 Sentence denotes METHODS:
T8 653-855 Sentence denotes This cross-sectional study included all patients (<18 years) with Crohn's disease or ulcerative colitis attending the out-patient clinic of one of three Dutch hospitals between March 2014 and June 2015.
T8 653-855 Sentence denotes This cross-sectional study included all patients (<18 years) with Crohn's disease or ulcerative colitis attending the out-patient clinic of one of three Dutch hospitals between March 2014 and June 2015.
T9 856-934 Sentence denotes Clinical disease activity was determined using the abbreviated-PCDAI or PUCAI.
T9 856-934 Sentence denotes Clinical disease activity was determined using the abbreviated-PCDAI or PUCAI.
T10 935-1017 Sentence denotes Biochemical disease activity was assessed using faecal calprotectin and serum CRP.
T10 935-1017 Sentence denotes Biochemical disease activity was assessed using faecal calprotectin and serum CRP.
T11 1018-1098 Sentence denotes IBS-symptoms were assessed using physician-administered Rome III-questionnaires.
T11 1018-1098 Sentence denotes IBS-symptoms were assessed using physician-administered Rome III-questionnaires.
T12 1099-1107 Sentence denotes RESULTS:
T12 1099-1107 Sentence denotes RESULTS:
T13 1108-1154 Sentence denotes We included 184 patients (92 female; mean age:
T13 1108-1154 Sentence denotes We included 184 patients (92 female; mean age:
T14 1155-1184 Sentence denotes 14.5 years) (Crohn's disease:
T14 1155-1184 Sentence denotes 14.5 years) (Crohn's disease:
T15 1185-1209 Sentence denotes 123, ulcerative colitis:
T15 1185-1209 Sentence denotes 123, ulcerative colitis:
T16 1210-1214 Sentence denotes 61).
T16 1210-1214 Sentence denotes 61).
T17 1215-1334 Sentence denotes The prevalence of IBS-type symptoms in children with inflammatory bowel disease in clinical remission was 6.4% (95% CI:
T17 1215-1334 Sentence denotes The prevalence of IBS-type symptoms in children with inflammatory bowel disease in clinical remission was 6.4% (95% CI:
T18 1335-1362 Sentence denotes 2.5-11.1%; Crohn's disease:
T18 1335-1362 Sentence denotes 2.5-11.1%; Crohn's disease:
T19 1363-1388 Sentence denotes 4.5%; ulcerative colitis:
T19 1363-1388 Sentence denotes 4.5%; ulcerative colitis:
T20 1389-1396 Sentence denotes 10.8%).
T20 1389-1396 Sentence denotes 10.8%).
T21 1397-1494 Sentence denotes Prevalence of IBS-type symptoms in children with faecal calprotectin <250 μg/g was 16.1% (95% CI:
T21 1397-1494 Sentence denotes Prevalence of IBS-type symptoms in children with faecal calprotectin <250 μg/g was 16.1% (95% CI:
T22 1495-1522 Sentence denotes 7.6-25.8%; Crohn's disease:
T22 1495-1522 Sentence denotes 7.6-25.8%; Crohn's disease:
T23 1523-1549 Sentence denotes 16.7%; ulcerative colitis:
T23 1523-1549 Sentence denotes 16.7%; ulcerative colitis:
T24 1550-1557 Sentence denotes 10.8%).
T24 1550-1557 Sentence denotes 10.8%).
T25 1558-1805 Sentence denotes No difference in faecal calprotectin or CRP was found between patients in clinical remission with or without IBS-type symptoms (faecal calprotectin: IBS+ median 58 μg/g, IBS- 221 μg/g, P = 0.12; CRP: IBS+ median 1.4 mg/L, IBS- 1.1 mg/L, P = 0.63).
T25 1558-1805 Sentence denotes No difference in faecal calprotectin or CRP was found between patients in clinical remission with or without IBS-type symptoms (faecal calprotectin: IBS+ median 58 μg/g, IBS- 221 μg/g, P = 0.12; CRP: IBS+ median 1.4 mg/L, IBS- 1.1 mg/L, P = 0.63).
T26 1806-1818 Sentence denotes CONCLUSIONS:
T26 1806-1818 Sentence denotes CONCLUSIONS:
T27 1819-1950 Sentence denotes The prevalence of IBS-type symptoms in children with inflammatory bowel disease is highly dependent on the definition of remission.
T27 1819-1950 Sentence denotes The prevalence of IBS-type symptoms in children with inflammatory bowel disease is highly dependent on the definition of remission.
T28 1951-2079 Sentence denotes Nonetheless, the prevalence is much lower than that previously reported in studies in adult inflammatory bowel disease patients.
T28 1951-2079 Sentence denotes Nonetheless, the prevalence is much lower than that previously reported in studies in adult inflammatory bowel disease patients.
T29 2080-2154 Sentence denotes IBS-type symptoms appear to be unrelated to gastrointestinal inflammation.
T29 2080-2154 Sentence denotes IBS-type symptoms appear to be unrelated to gastrointestinal inflammation.